Pharma giant Regeneron to buy 23andMe and its customers' data for $256M
1. Regeneron to acquire 23andMe for $256 million post-bankruptcy auction. 2. Acquisition includes access to 15 million customers' genetic data. 3. 23andMe previously filed for bankruptcy after a data breach compromised customer information. 4. Concerns arose about the potential unethical sale of customer data during bankruptcy. 5. Regeneron aims to use the acquired data for drug discovery while ensuring compliance.